Clough Capital Partners L P Wave Life Sciences Ltd. Transaction History

Clough Capital Partners L P

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$7.99 - $37.6 $472,017 - $2.22 Million	-59,076 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$19.17 - $27.4 $23,004 - $32,880	-1,200 Reduced 1.99%	59,076 $1.21 Million
Q2 2019 Aug 14, 2019	BUY	$22.93 - $42.84 $199,491 - $372,708	8,700 Added 16.87%	60,276 $1.57 Million
Q1 2019 May 15, 2019	SELL	$32.69 - $47.91 $29,420 - $43,119	-900 Reduced 1.72%	51,576 $2 Million
Q4 2018 Feb 14, 2019	SELL	$37.1 - $50.11 $587,181 - $793,090	-15,827 Reduced 23.17%	52,476 $2.21 Million
Q3 2018 Nov 14, 2018	SELL	$36.35 - $55.2 $2.25 Million - $3.41 Million	-61,800 Reduced 47.5%	68,303 $3.42 Million
Q2 2018 Aug 14, 2018	BUY	$33.85 - $50.65 $416,355 - $622,995	12,300 Added 10.44%	130,103 $4.98 Million
Q1 2018 May 15, 2018	SELL	$32.45 - $54.7 $1.35 Million - $2.28 Million	-41,600 Reduced 26.1%	117,803 $4.72 Million
Q4 2017 Feb 14, 2018	SELL	$21.8 - $39.35 $1.07 Million - $1.94 Million	-49,300 Reduced 23.62%	159,403 $5.6 Million
Q3 2017 Nov 14, 2017	BUY	$16.4 - $25.05 $3.42 Million - $5.23 Million	208,703	208,703 $4.54 Million

175

120M

148K

109K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $947M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

Stay updated on Clough Capital Partners L P with notifications on news.